✦ LIBER ✦

Absorption of the oral bisphosphonate alendronate in osteoporotic patients with Crohn’s disease

✍ Scribed by Serge C. L. M. Cremers; Ruud van Hogezand; Denise Bänffer; Jan den Hartigh; Pieter Vermeij; Socrates E. Papapoulos; Neveen A. T. Hamdy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of celiac disease in patients

✍ Gerassimos J Mantzaris; Anastassios Roussos; Stavroula Koilakou; Kalliopi Petrak 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

The management of fistulizing oral Crohn

✍ K. S. Staines; R. Green; D. H. Felix 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Factors affecting long-term compliance o

✍ Masayuki Kamatari; Shiro Koto; Nobuhiro Ozawa; Chie Urao; Yumiko Suzuki; Eri Aka 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 244 KB

The Risk of Cancer in Patients with Croh

✍ Alexander C. von Roon; George Reese; Julian Teare; Vasilis Constantinides; Ara W 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 295 KB

The faecal flora of patients with Crohn'

✍ F. Wensinck 📂 Article 📅 1975 🏛 Springer Netherlands 🌐 English ⚖ 98 KB

Low dose of oral alendronate decreases b

✍ Junichi Takada; Kousuke Iba; Toshihiko Yamashita 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 197 KB